abionic

Abionic is a Swiss-based startup that specializes in rapid in vitro diagnostic (IVD) testing. This means they provide tests that can detect diseases or other conditions using samples like blood or tissue that have been taken from the human body. Their innovative approach uses proprietary nanofluidic technology, which involves manipulating small amounts of fluids on a nanoscale, to analyze up to 14 parameters simultaneously from just one drop of blood. This process takes about 5 minutes, providing healthcare professionals with quick, laboratory-quality results.

The company's main product is the abioSCOPE platform, which offers cost-effective, ultra-rapid panel solutions at the point of care. This means that tests can be conducted and results can be obtained right at the patient's bedside, rather than having to send samples to a lab and wait for results. This rapid turnaround time is a significant advantage in urgent care situations where time is of the essence.

Abionic's business model is based on selling these diagnostic tests to healthcare professionals. Their clients include hospitals, clinics, and other healthcare facilities. They operate in the healthcare market, specifically in the in vitro diagnostics sector. The company makes money by selling their testing kits and the proprietary technology that goes with them.

In summary, Abionic is a healthcare technology startup that provides rapid, accurate, and easy-to-use diagnostic tests to healthcare professionals. Their innovative use of nanofluidic technology and their ability to deliver results at the point of care sets them apart in the in vitro diagnostics market.

Keywords: Healthcare, In Vitro Diagnostics, Rapid Testing, Nanofluidic Technology, Point of Care, abioSCOPE Platform, Swiss Startup, Healthcare Professionals, Diagnostic Tests, Proprietary Technology.